Intragastric stimulation is ineffective after failed adjustable gastric banding.
BACKGROUND
Gastric pacing has gained popularity as an effective and safe minimally invasive procedure to treat morbid obesity. This study evaluates the outcome of gastric pacing as a bariatric re-do procedure in patients who developed failure after adjustable gastric banding (AGB) due to band migration.


METHODS
8 patients were enrolled in this analysis. After implantation of an AGB, they had developed band failure due to band migration. The implantable gastric stimulator (IGS) was implanted laparoscopically as a second-line operation after gastroscopic removal of the band.


RESULTS
Median time (range) from AGB complication to implantation of the IGS was 42 (10.3-50.3) months. During that time, all 8 patients had regained significant weight. All IGS devices could be implanted laparoscopically, without intra- or perioperative complications. The minimal body weight following IGS implantation was reached after 5 (0-12) months. The median observation time was 23 (11.3-27.5) months. 1 year after IGS implantation (n=7), median weight was 116 (98-165) kg, equivalent to a median BMI of 41.1 (36.055.8) kg/m(2), which is not statistically different to preoperative values and therefore prompted us to stop our ongoing trial. In all but 2 patients, the IGS device was explanted. During the same procedure, patients underwent a gastric sleeve resection (n=4) or a Roux-en-Y gastric bypass (n=2).


CONCLUSIONS
The implantation of an IGS was an ineffective second-line operation after AGB migration.
Hoeller
Elisabeth
E
Medical University Innsbruck, Department of General and Transplant Surgery, Innsbruck, Austria.
Aigner
Franz
F
Margreiter
Raimund
R
Weiss
Helmut
H
D034861:Abdominal Wall; D000328:Adult; D004599:Electric Stimulation Therapy; D004567:Electrodes, Implanted; D004868:Equipment Failure; D005260:Female; D005500:Follow-Up Studies; D015391:Gastroplasty / Q000295:instrumentation*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009767:Obesity, Morbid / Q000628:therapy*; D019233:Retreatment; D012189:Retrospective Studies; D016896:Treatment Outcome; D015431:Weight Loss